aTYR PHARMA INC (ATYR)
Latest ATYR Insider Trades
- Paul SchimmelOpen-market purchase$50K
Sanjay Shukla - OfficerOpen-market sale$4K- Jill Marie Broadfoot
About aTYR PHARMA INC (ATYR)
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
- SAN DIEGO, CA
- 58
- 2015
- XNAS
90-Day SEC Filing Activity
No Form 4 activity for ATYR in the last 90 days.
ATYR Insider Transactions (Form 4)
2316 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Paul Schimmel | Open-market purchase | Common Stock | 100,000 | $0.50 |
Recent ATYR Form 8-K Filings
5ATYR Insider Trading - FAQ
What is the latest insider trade for ATYR?
aTYR PHARMA INC (ATYR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-28. The full record for ATYR runs to 16 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ATYR stock?
No insider purchases of ATYR were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ATYR stock?
No insider sales of ATYR were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ATYR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ATYR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ATYR insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ATYR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Paul Schimmel view on EDGAR
- - Timothy Coughlin view on EDGAR
- - Eric Benevich view on EDGAR
- - Jane A. Gross view on EDGAR
- - Svetlana Lucas view on EDGAR
- - Sara Zaknoen view on EDGAR
- - Paul Schimmel view on EDGAR
- - Sanjay Shukla view on EDGAR
- - Jill Marie Broadfoot view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ATYR's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ATYR insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
